Clinical trials recruiting for Estrogen-receptor-low Breast Cancer
Fewer than 3 recruiting trials found.
1
Recruiting trials
5
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| SOC Chemotherapy | 1 |
| Tocilizumab/Tocilizumab Biosimilar | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 1 |
| Indiana | 1 |
| Kentucky | 1 |
| New York | 1 |
| North Carolina | 1 |
Top cities
Atlanta, Georgia 1Buffalo, New York 1Carmel, Indiana 1Durham, North Carolina 1Indianapolis, Indiana 1Lexington, Kentucky 1
Self-screener
Recruiting trials
Related conditions
Trials recruiting for Estrogen-receptor-low Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Triple-negative breast cancer 138Metastatic breast cancer 131ER Positive, HER2 Negative Breast Cancer 3Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Estrogen-receptor-low Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.